Structural basis of neuropeptide Y signaling through Y

G protein coupled receptor ligand selectivity neuropeptide Y neuropeptide Y receptors

Journal

MedComm
ISSN: 2688-2663
Titre abrégé: MedComm (2020)
Pays: China
ID NLM: 101769925

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 22 11 2023
revised: 20 02 2024
accepted: 02 03 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

Neuropeptide Y (NPY), a 36-amino-acid peptide, functions as a neurotransmitter in both the central and peripheral nervous systems by activating the NPY receptor subfamily. Notably, NPY analogs display varying selectivity and exert diverse physiological effects through their interactions with this receptor family. [Pro

Identifiants

pubmed: 38882210
doi: 10.1002/mco2.565
pii: MCO2565
pmc: PMC11179954
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e565

Informations de copyright

© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Auteurs

Siyuan Shen (S)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
Frontiers Medical Center Tianfu Jincheng Laboratory Chengdu China.

Yue Deng (Y)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Chenglong Shen (C)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Haidi Chen (H)

Institutes for Systems Genetics Frontiers Science Centre for Disease‑Related Molecular Network West China Hospital Sichuan University Chengdu Sichuan China.

Lin Cheng (L)

Department of Otolaryngology Head and Neck Surgery Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu China.

Chao Wu (C)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Chang Zhao (C)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Zhiqian Yang (Z)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Hanlin Hou (H)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Kexin Wang (K)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Zhenhua Shao (Z)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
Frontiers Medical Center Tianfu Jincheng Laboratory Chengdu China.

Cheng Deng (C)

Institutes for Systems Genetics Frontiers Science Centre for Disease‑Related Molecular Network West China Hospital Sichuan University Chengdu Sichuan China.

Feng Ye (F)

Department of Pathology Institute of Clinical Pathology Frontiers Science Center for Disease-related Molecular Network West China Hospital of Sichuan University Chengdu China.

Wei Yan (W)

Division of Nephrology and Kidney Research Institute State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.

Classifications MeSH